Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KLA Corp. (KLAC) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

KLA Corp. vs Recursion Pharmaceuticals Inc — how do they compare? KLA Corp. trades at $204.58 (market cap $261.92B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: KLA Corp. is far larger — about 144.7× Recursion Pharmaceuticals Inc's market cap, and KLA Corp. pays a 0.46% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

KLACRXRX
Market Cap
$261.92B$1.81B
Sector
TechnologyHealth
52-Week High
$301.71$6.79
52-Week Low
$84.39$2.84
Enterprise Value
$263.17B$1.33B
Dividend Yield
0.46%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About KLA Corp.

KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.

Read more on KLAC

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX